SPIR Q1 2026 Earnings Earnings Miss Meets Positive Stock Reaction Amid Strategic Shifts TMHC Q1 2026 Earnings EPS Surges Past Estimates by 2856 GAP Q1 2026 Earnings EPS Misses Estimates as Narrow Beat Fails to Materialize Armata Pharmaceuticals ARMP Q1 2026 Earnings Steep EPS Miss as ClinicalStage Biotech Continues Heavy RD Spending QMCO Q1 2026 Earnings EPS Beats Estimates by 216 Stock Gains ADM Q1 2026 Earnings EPS Beats Estimates Amid Cautious Market Environment